Aventis Ketek Recommended For Pneumonia, Sinusitis, And Bronchitis

Aventis' Ketek should gain approval for the treatment of community-acquired pneumonia, acute exacerbations of chronic bronchitis and acute sinusitis, FDA's Anti-Infective Drugs Advisory Committee agreed Jan. 8

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet